New AI-Powered Cancer Drugs Fuel Share Rally Of Korea's Voronoi, Minting A New Billionaire
The company, which had no revenue last year and $5.1 million in sales for the first nine months of this year with widening losses, boasts a $2.9 billion market cap.
(Forbes, 2025-11-18T16:30:58Z)